Tackling Patient Compliance With Oral Drug Formulations

This technical report discusses the challenges associated with patient compliance in oral drug formulations, particularly focusing on the use of ion exchange resins (IERs) to mask the bitter taste of medications. The report outlines how oral medications, while convenient, often face compliance issues due to their unpleasant taste, especially in vulnerable populations such as pediatric and geriatric patients. It details the role of IERs in pharmaceutical formulations, explaining their ability to enhance drug stability, solubility, and controlled release. The report also presents various methods for taste masking, including the use of flavors, coatings, and IERs, emphasizing the importance of selecting appropriate strategies based on the specific active pharmaceutical ingredients (APIs). Furthermore, it highlights the potential of IERs to improve patient experiences and outcomes by enabling the development of more palatable and effective oral dosage forms, thereby supporting adherence to treatment regimens.